Filing
1st Quarter - Report
Lobbying activity
2
Duchenne Muscular Dystrophy and Rare Disease Patient Access to Treatments Newborn Screening for Rare Diseases
Scientific Innovation in Healthcare Gene Therapies Artificial Intelligence and Data Governance